Komori
ASKA Pharmaceutical Holdings (4886) · PolicyRestated

Revitalizing the Board by Separating Decision-Making and Oversight From Execution

First written in FY2022-Q1. 5 of 6 entries say "Restated". Latest entry: FY2024.

6entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY20242021: 220212022: 220222023: 120232024: 12024
Same theme, other companies
Functional Separation Between the Board of Directors and Executive Officers and Faster Decision-MakingA theme 399 companies write about · 0 as a headwind · 400 as a tailwind

105 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 400 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「We separate management from execution through the executive officer system: executive officers execute business operations, while directors focus exclusively on management and oversight.」

    執行役員制度による経営・監督と執行の分離を再確認している。
  2. FY2023RestatedAnnual report

    「We separate management from execution through the executive officer system: executive officers execute business operations, while directors focus exclusively on management and oversight.」

    執行役員制度による経営・監督と執行の分離を再確認している。
  3. FY2022RestatedAnnual report

    「We separate management from execution through the executive officer system: executive officers execute business operations, while directors focus exclusively on management and oversight.」

    経営・監督と執行を分離する執行役員制度の運用方針を再掲している。
  4. FY2022-Q3RestatedAnnual report

    「We have introduced an executive officer system to revitalize the Board of Directors by separating decision-making and oversight from execution.」

    意思決定・監督と執行を分離する執行役員制度の導入方針を役員情報の注記で再掲している。
  5. FY2022-Q2RestatedAnnual report

    「We have introduced an executive officer system to revitalize the Board of Directors by separating decision-making and oversight from execution.」

    執行役員制度により意思決定・監督と執行を分離するガバナンス方針を再掲している。
  6. FY2022-Q1First statedAnnual report

    「We have introduced an executive officer system to revitalize the Board of Directors by separating decision-making and oversight from execution.」

    The company introduced an executive officer system to separate decision-making and oversight from execution and revitalize the Board of Directors.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.